Acadia Pharmaceuticals | ACAD - Capitalizzazione Di Mercato





Capitalizzazione Di Mercato Cambiamento Data
Acadia Pharmaceuticals USD 3.57B 221M 2026-05
ALKERMES USD 5.66B 217M 2026-05
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.18B 683M 2026-05
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Cara Therapeutics USD 366M 338M 2025-09
Corcept Therapeutics USD 4.32B 654M 2026-03
Cytokinetics USD 9.16B 975M 2026-05
Eisai JPY 1.25T 171.13B 2026-05
Eli Lilly USD 869.02B 146.97B 2026-03
Incyte USD 21.73B 3B 2026-05
J&J USD 579.15B 78.91B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Neurocrine Biosciences USD 15.15B 1.9B 2026-05
Pfizer USD 147.4B 6.42B 2026-05
Prothena USD 514M 11M 2025-12
PTC Therapeutics USD 4.94B 698M 2026-05
Sarepta Therapeutics USD 2.16B 123M 2026-05
Ultragenyx Pharmaceutical USD 2.06B 1000K 2026-05
Vanda Pharmaceuticals USD 279M 6M 2024-12
Vertex Pharmaceuticals USD 113.58B 1000K 2026-05